Tag Archives: Medical Technology

Medicine: ‘Single Drop’ Blood Testing Advances

“Even more importantly, we’ve shown you can collect the blood drop at home and mail it into the lab,” said Michael Snyder, PhD, director of the Center for Genomics and Personalized Medicine and senior author on the research, which was published in Nature Biomedical Engineering on Jan. 19.

Stanford Medicine (January 19, 2023) – Researchers at Stanford Medicine have shown they can measure thousands of molecules — some of which are signals of health — from a single drop of blood.

Unlike finger-prick testing for diabetes, which measures a single type of molecule (glucose), multi-omics microsampling gives data about thousands of different molecules at once.

finger prick
A single drop of blood can yield measurements for thousands of proteins, fats and other biomarkers, researchers at Stanford Medicine found.

The new approach combines a microsampling device — a tool used to self-administer a finger prick — with “multi-omics” technologies, which simultaneously analyze a vast array of proteins, fats, by-products of metabolism and inflammatory markers.

Women’s Health: ‘Google AI’ Partners With iCAD For Improved Mammograms

GregCorrado800

Greg Corrado – Ph.D., Head of Health AI, November 28, 2022:

Alongside licensing our AI technology, iCAD will also use Google Cloud’s secure, scalable infrastructure, giving them the ability to rapidly expand cloud-hosted solutions into new regions. By doing so, iCAD can scale access to AI-based tools in underserved regions where infrastructure challenges may constrain their ability to offer breast cancer screenings.

Breast cancer is one of the world’s most common cancers; thankfully, early detection can help save lives and improve outcomes among many who develop the disease. At Google Health we’re developing AI to improve the accuracy and expand the availability of breast cancer screenings. Over time, better screenings will improve health outcomes and reduce disparities for people around the world.

Today, we’re announcing a partnership with iCAD, a leader in medical technology and cancer detection, marking the first time we are licensing our mammography AI research model. iCAD will work toward validating and incorporating our mammography AI technology with its products for use in clinical practices with the goal of improving breast cancer detection and assessment of short-term personal cancer risk for the more than two million people globally diagnosed with breast cancer every year.

READ MORE

Covid-19: Can A Vaccine Be Developed That Lasts?

“Roughly two and a half years into the pandemic, White House officials and health experts have reached a pivotal conclusion about Covid-19 vaccines: The current approach of offering booster shots every few months isn’t sustainable.

Though most vaccines take years to develop, the Covid shots now in use were created in record time—in a matter of months. For health authorities and a public desperate for tools to deal with the pandemic, their speedy arrival provided a huge lift, preventing hospitalizations and deaths while helping people to escape lockdowns and return to work, school and many other aspects of pre-Covid life.”

Technology: How AI Is Helping To Cure Blindness

England’s health service handles 10m clinic appointments for eyes every year. Artificial intelligence could help speed up and improve diagnoses for patients.

Telemedicine: Growth Rate Peaked In April 2020, Stabilized During 2021

A year ago, we estimated that up to $250 billion of US healthcare spend could potentially be shifted to virtual or virtually enabled care. Approaching this potential level of virtual health is not a foregone conclusion. It would likely require sustained consumer and clinician adoption and accelerated redesign of care pathways to incorporate virtual modalities.

  • Telehealth utilization has stabilized at levels 38X higher than before the pandemic. After an initial spike to more than 32 percent of office and outpatient visits occurring via telehealth in April 2020, utilization levels have largely stabilized, ranging from 13 to 17 percent across all specialties.2 This utilization reflects more than two-thirds of what we anticipated as visits that could be virtualized.3
  • Similarly, consumer and provider attitudes toward telehealth have improved since the pre-COVID-19 era. Perceptions and usage have dropped slightly since the peak in spring 2020. Some barriers—such as perceptions of technology security—remain to be addressed to sustain consumer and provider virtual health adoption, and models are likely to evolve to optimize hybrid virtual and in-person care delivery.
  • Some regulatory changes that facilitated expanded use of telehealth have been made permanent, for example, the Centers for Medicare & Medicaid Services’ expansion of reimbursable telehealth codes for the 2021 physician fee schedule. But uncertainty still exists as to the fate of other services that may lose their waiver status when the public health emergency ends.
  • Investment in virtual care and digital health more broadly has skyrocketed, fueling further innovation, with 3X the level of venture capitalist digital health investment in 2020 than it had in 2017.4
  • Virtual healthcare models and business models are evolving and proliferating, moving from purely “virtual urgent care” to a range of services enabling longitudinal virtual care, integration of telehealth with other virtual health solutions, and hybrid virtual/in-person care models, with the potential to improve consumer experience/convenience, access, outcomes, and affordability.

Read more at McKinsey & Company

Health: Hip Replacement Surgery Success Rates

The mission of COMPASS is to provide patients with access to comprehensive quality and safety data across a variety of Massachusetts General Hospital surgical specialties. In this video, learn about performance data for Mass General hip replacement surgery including its success rate and recovery and rehabilitation.

Medicine: ‘AI’ Can Predict Rheumatoid Arthritis

Medicine: The Future Of ‘MR Technology’ (Video)

We’re already integrating Adaptive Intelligence-powered applications into our MR systems, improving workflow and patient comfort, increasing diagnostic confidence, and increasing speed.

We’re already integrating Adaptive Intelligence-powered applications into our MR systems, improving workflow and patient comfort, increasing diagnostic confidence, and increasing speed.

Our Ingenia digital MR portfolio integrates Adaptive Intelligence-driven SmartExam analytics for automatic planning, scanning and processing of exams, helping improve the entire MR workflow, from image acquisition to reading preference.

Medicine: Robotically Assisted Heart Surgery

Robotically assisted heart surgery is a minimally invasive option most often used for mitral valve repair. Cleveland Clinic cardiothoracic surgeons explain how it works and what to expect.

Read more